.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents and 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
QuintilesIMS
Queensland Health
Julphar
Johnson and Johnson
Argus Health
Daiichi Sankyo
Cerilliant
Federal Trade Commission

Generated: June 24, 2017

DrugPatentWatch Database Preview

TRICHLORMETHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Trichlormethiazide, and what generic Trichlormethiazide alternatives are available?

Trichlormethiazide is a drug marketed by Par Pharm, Watson Labs, Impax Labs, Tg United Labs, and Sandoz. and is included in eleven NDAs.

The generic ingredient in TRICHLORMETHIAZIDE is reserpine; trichlormethiazide. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine; trichlormethiazide profile page.

Summary for Tradename: TRICHLORMETHIAZIDE

Patents:0
Applicants:5
NDAs:11
Bulk Api Vendors: see list38
Patent Applications: see list2,200
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRICHLORMETHIAZIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
TRICHLORMETHIAZIDE
trichlormethiazide
TABLET;ORAL087005-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
TRICHLORMETHIAZIDE
trichlormethiazide
TABLET;ORAL085962-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
TRICHLORMETHIAZIDE
trichlormethiazide
TABLET;ORAL083855-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Impax Labs
TRICHLORMETHIAZIDE
trichlormethiazide
TABLET;ORAL083967-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Par Pharm
TRICHLORMETHIAZIDE
trichlormethiazide
TABLET;ORAL087007-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Dow
Moodys
Cerilliant
Boehringer Ingelheim
Fish and Richardson
Daiichi Sankyo
UBS
Healthtrust
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot